According to Biofrontera's latest financial reports the company's current EPS (TTM) is -HK$132.71. In 2022 the company made an earnings per share (EPS) of HK$10.96 an increase over its 2021 EPS that were of -HK$521.94.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -HK$134.20 | -1324.29% |
2022 | HK$10.96 | -102.1% |
2021 | -HK$521.94 |